Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2026

Earnings Per Share [Abstract]

Schedule of Anti-dilutive Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share

The following equity instruments were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:


		Nine months ended September 30,
		2026				2025
Awards under equity incentive plan			12,364,434				13,209,871
Non-vested restricted shares and restricted stock units			6,898,500				4,093,000
Warrants to purchase common stock(*)			77,793				77,793
Total			19,340,727				17,380,664

* Pre-funded warrants are excluded herein.

Reconciles Basic net loss Per Share and Diluted net loss Per Share of Common Stock

The following table calculates basic net loss per share of common stock and diluted net loss per share of common stock for the three and nine months ended September 30, 2026 and 2025 (in thousands, except share and per share amounts):


		Three months ended September 30,								Nine months ended September 30,
		2026				2025				2026				2025
Net loss		$	(42,989	)		$	(29,561	)		$	(120,501	)		$	(86,601	)
Net loss attributable to common stockholders			(42,989	)			(29,561	)			(120,501	)			(86,601	)
Undistributed earnings and net loss attributable to common stockholders, basic and diluted			(42,989	)			(29,561	)			(120,501	)			(86,601	)
Weighted-average common shares outstanding, basic and diluted			254,219,719				216,462,161				253,799,570				216,347,963
Basic and diluted net loss per share		$	(0.17	)		$	(0.14	)		$	(0.47	)		$	(0.40	)